ReviewThe Journal of clinical investigation2025

GLP-1 agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity.

Mark E Cooper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.